Literature DB >> 6145185

Behavioural pharmacology of benzodiazepines.

S E File.   

Abstract

Acute injections of benzodiazepines produce sedative effects in the rat that can be detected by decreases in spontaneous motor activity and exploration. The effects are found with low doses, are dose-related and correlate well with plasma concentrations. With repeated daily doses there is tolerance to the sedative effects within 3-5 days even with benzodiazepines with short half-lives and no active metabolites. In the rat there may be some pharmacokinetic tolerance accounting for some of the behavioural tolerance, but pharmacokinetic changes cannot explain the tolerance to low doses of chlordiazepoxide. With chronically treated rats there is no relationship between plasma benzodiazepine concentrations and sedation. There is rapid recovery from tolerance to the sedative effects and if the animals are tested undrugged there is no detectable effect 24 h after the last dose. Anxiolytic effects emerge after a few days of benzodiazepine treatment, but after 10-20 days of treatment there is tolerance to these effects in the social interaction test and in the corticosterone-stress response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145185     DOI: 10.1016/0278-5846(84)90132-5

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  15 in total

1.  Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.

Authors:  C Dugovic; T F Meert; D Ashton; G H Clincke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.

Authors:  S E File; J Dingemanse; H L Friedman; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Differential effects of lorazepam on sleep and activity in C57BL/6J and BALB/cJ strain mice.

Authors:  Xiangdong Tang; Linghui Yang; Nancy F Fishback; Larry D Sanford
Journal:  J Sleep Res       Date:  2009-09       Impact factor: 3.981

Review 4.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Dose-dependent impairment in the performance of a go-no go successive discrimination by chlordiazepoxide.

Authors:  S O Cole; A Michaleski
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity.

Authors:  D N Stephens; H H Schneider
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Sedation and disruption of maternal motivation underlie the disruptive effects of antipsychotic treatment on rat maternal behavior.

Authors:  Changjiu Zhao; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2008-11-17       Impact factor: 3.533

Review 8.  Antipsychotic drugs on maternal behavior in rats.

Authors:  Ming Li
Journal:  Behav Pharmacol       Date:  2015-09       Impact factor: 2.293

9.  Impairment of decision making in rats by diazepam: implications for the "anticonflict" effects of benzodiazepines.

Authors:  T Ljungberg; L Lidfors; M Enquist; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Development of tolerance to anxiolytic effects of chlordiazepoxide in elevated plus-maze test and decrease of GABAA receptors.

Authors:  S Ishihara; M Hiramatsu; T Kameyama; T Nabeshima
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.